K

Kindly MD Inc
NASDAQ:KDLY

Watchlist Manager
Kindly MD Inc
NASDAQ:KDLY
Watchlist
Price: 10.9 USD -5.71%
Market Cap: $120.8m

P/B

79
Current
528%
More Expensive
vs 3-y average of 12.6

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
79
=
Market Cap
$120.8m
/
Total Equity
$1.5m

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
79
=
Market Cap
$120.8m
/
Total Equity
$1.5m

Valuation Scenarios

Kindly MD Inc is trading above its 3-year average

If P/B returns to its 3-Year Average (12.6), the stock would be worth $1.74 (84% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-97%
Maximum Upside
No Upside Scenarios
Average Downside
90%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 79 $10.9
0%
3-Year Average 12.6 $1.74
-84%
5-Year Average 12.6 $1.74
-84%
Industry Average 3.1 $0.43
-96%
Country Average 2.5 $0.35
-97%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
Market Cap P/B P/E
US
Kindly MD Inc
NASDAQ:KDLY
120.8m USD 79 -27.6
US
CVS Health Corp
NYSE:CVS
100.2B USD 1.3 55.9
US
Cigna Group
XMUN:CGN
68.5B EUR 1.9 13.5
US
Cigna Corp
NYSE:CI
73.7B USD 1.7 12.1
DE
Fresenius Medical Care AG
XMUN:FME
23.1B EUR 1.7 23.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
22.7B EUR 1.2 17.9
US
Quest Diagnostics Inc
NYSE:DGX
22.1B USD 2.9 21.2
US
Laboratory Corporation of America Holdings
NYSE:LH
21.8B USD 2.5 24.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR 0.8 11.1
US
Guardant Health Inc
NASDAQ:GH
11.5B USD -115.6 -27.6
US
DaVita Inc
NYSE:DVA
10.6B USD -15.9 13.8
P/E Multiple
Earnings Growth PEG
US
K
Kindly MD Inc
NASDAQ:KDLY
Average P/E: 21.5
Negative Multiple: -27.6
N/A N/A
US
CVS Health Corp
NYSE:CVS
55.9
90%
0.6
US
C
Cigna Group
XMUN:CGN
13.5
19%
0.7
US
Cigna Corp
NYSE:CI
12.1
19%
0.6
DE
Fresenius Medical Care AG
XMUN:FME
23.6
15%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
17.9
25%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
21.2
12%
1.8
US
Laboratory Corporation of America Holdings
NYSE:LH
24.7
27%
0.9
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.1
15%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -27.6 N/A N/A
US
DaVita Inc
NYSE:DVA
13.8
19%
0.7

Market Distribution

Higher than 99% of companies in the United States of America
Percentile
99th
Based on 10 946 companies
99th percentile
79
Low
0 — 1.5
Typical Range
1.5 — 4.8
High
4.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.5
Median 2.5
70th Percentile 4.8
Max 147 580.5

Kindly MD Inc
Glance View

Market Cap
120.8m USD
Industry
Health Care

Kindly MD, Inc. provided healthcare services. The company is headquartered in Salt Lake City, Utah and currently employs 23 full-time employees. The company went IPO on 2024-05-31. The firm offers direct health care to patients, integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a fee-for-service basis. The firm offers evaluation and management, including, but not limited to, chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. The firm also collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The firm captures all relevant data points to assist and appropriately treat each individual patient.

KDLY Intrinsic Value
0.57 USD
Overvaluation 95%
Intrinsic Value
Price $10.9
K
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett